• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Matters in Managed Care: Investing in Primary Care—New Collaborations for the Postpandemic Era, Part 5

Webinar

In the June Matters in Managed Care webinar, experts from Blue Cross and Blue Shield of North Carolina, Duke-Margolis Center for Health Policy, UNC Center for the Business of Health, and WakeMed discussed how they are working together to address some of the state’s unique primary care needs.

The COVID-19 pandemic magnified the crucial role of primary care in advancing population health. Payers and providers are collaborating in novel ways to expand access to quality, affordable primary care.

In the latest Matters in Managed Care webinar from The American Journal of Managed Care® (AJMC)®, experts from Blue Cross and Blue Shield of North Carolina, Duke-Margolis Center for Health Policy, UNC Center for the Business of Health, and WakeMed sat down to discuss how payers and primary care providers are managing patient needs during this time of pandemic change, including efforts to expand access to value-based care and connect behavioral/mental health, health equity, and primary care.

Brian Klausner, MD, medical director, Community Population Health at WakeMed Primary Care, moderated the June 2021 discussion with Devdutta Sangvai, MD, MBA, vice president, Population Health Management, Duke University Health System; Leslie McKinney, MD, FACEP, senior medical director, Blue Cross NC Advanced Primary Care and Value-Based Provider Engagement; and Rivers Woodward, MD, MBA, family physician, and Blue Ridge Community Health Services.

In part 5, the panel discusses the integration behavioral and mental health into primary care.

Watch Segment 1

Watch Segment 2

Watch Segment 3

Watch Segment 4

Watch Segment 6

Watch Segment 7

Watch Segment 8


Related Videos
Dr Guru Sonpavde
Video 2 - "Adverse Events & Existing Treatment Options for Dry Eye Disease"
Overview of Dry Eye Disease (DED) Causes and Treatments
Video 12 - "Harnessing Indication-Specific Data on Biosimilars"
Video 11 - "An Overview of Biosimilar Extrapolation During FDA Approval"
Video 3 - "Overview of BCG-Unresponsive Bladder Cancer Treatments Landscape"
Video 2 - "Bladder Cancer with FGFR Alterations: THOR-2 Cohort 1 Study at ESMO 2023"
Related Content
© 2023 MJH Life Sciences
AJMC®
All rights reserved.